Experimental osteoporosis induced in female albino rats and its antagonism by Indian black scorpion (Heterometrus bengalensis C.L.Koch) venom

Toxicon

Volumn 53, Issue 1, 2009, Pages 60-68

  Gomes, Antony ^a   Haldar, Subhash ^a   Giri, Biplab ^a   Mishra, Roshnara ^a   Saha, Archita ^a   Dasgupta, Shubho ^b   Gomes, Aparna ^b  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Experimental osteoporosis; Heterometrus bengalensis; Osteoporosis; Scorpion; Scorpion venom

Indexed keywords

CALCIUM; INTERLEUKIN 1; INTERLEUKIN 6; MAGNESIUM; PARATHYROID HORMONE; SCORPION VENOM; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HETEROMETRUS BENGALENSIS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SCORPION; URINALYSIS;

ANIMALS; BONE AND BONES; BONE DENSITY; FEMALE; MALE; METHYLPREDNISOLONE; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, INBRED WF; SCORPION VENOMS; SCORPIONS;

ANIMALIA; HETEROMETRUS; HETEROMETRUS FULVIPES; RATTUS; SCORPIONES;

EID: 57749094732     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.10.011     Document Type: Article

References (39)

1. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., and Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 6656 (1997) 175-179
2. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13 4-5 (2002) 323-340
3. Bai Y.D., Yang F.S., Xuan K., Bai Y.X., and Wu B.L. Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med. Hypotheses 71 2 (2008) 256-258
4. Bartels H., Böhmer M., and Heierli C. Serum creatinine determination without protein precipitation. Clin. Chim. Acta 37 (1972) 193-197
5. Burtis C.A., and Ashwood E.R. Tietz Fundamentals of Clinical Chemistry. third ed. (2001), W.B. Saunders Company, Philadelphia pp. 617-721
6. Connerty H.V., and Briggs A.R. Determination of serum calcium by means of sodium alizarinsulfonate. Clin. Chem. 11 (1965) 716-728
7. Dasgupta S., Debnath A., Saha A., Giri B., Tripathi G., Vedasiromoni J.R., Gomes A., and Gomes A. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk. Res. 31 6 (2007) 817-825
8. Exley D., and Abuknesha R.A. Highly sensitive and specific enzyme immunoassay method for oestradiol-17 beta. FEBS Lett. 191 2 (1978) 162-165
9. Flynn A. The role of dietary calcium in bone health. Proc. Nutr. Soc. 62 4 (2003) 851-858
10. Fu Y.J., Yin L.T., Liang A.H., Zhang C.F., Wang W., Chai B.F., Yang J.Y., and Fan X.J. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci. Lett. 412 1 (2007) 62-67
11. Gambacciani M., and Ciaponi M. Postmenopausal osteoporosis management. Curr. Opin. Obstet. Gynecol. 12 3 (2000) 189-197
12. Goldstein S.R., Siddhanti S., Ciaccia A.V., and Plouffe L.J. A pharmacological review of selective oestrogen receptor modulators. Hum. Reprod. Update 6 3 (2000) 212-224
13. Gorman C., Gambacciani M., Ciaponi M., and Park A. The truth about hormones. Time 160 4 (2002) 32-39
14. Haugeberg G., Griffiths B., Sokoll K.B., and Emery P. Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short-term prospective observational study. Ann. Rheum. Dis. 63 8 (2004) 940-944
15. Heymann M.F., Riet A., Le Goff B., Battaglia S., Paineau J., and Heymann D. OPG, RANK and Rankl ligand expression in thyroid lesions. Regul. Pept. 148 1-3 (2008) 46-53
16. Hillmann G. Continuous photometric measurement of prostate acid phosphatase activity. Z. Klin. Chem. Klin. Biochem. 9 3 (1971) 273-274
17. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16 3-4 (1998) 249-284
18. Inceoglu B., Lango J., Jing J., Chen L., Doymaz F., Pessah I.N., and Hammock B.D. One scorpion, two venoms: prevenom of parabuthus transvaalicus acts as an alternative type of venom with mechanism of action. Proc. Natl. Acad. Sci. U. S. A. 100 3 (2003) 922-927
19. Kaji H. Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment. Clin. Calcium 17 12 (2007) 1836-1842
20. Khosla S. The OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5505
21. Kruger L., Rosenblum S., Zaara J., and Wong J. Intact PTH is stable in unfrozen EDTA plasma for 48 hours prior to laboratory analysis. Clin. Chem. 41 6 (1995) S47
22. Kwon J., Chung I.Y., and Benveniste E.N. Cloning and sequence analysis of the rat tumor necrosis factor-encoding genes. Gene 132 2 (1993) 227-236
23. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., and Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 2 (1998) 165-176
24. Lawrence G.R., and Gideon A.R. Pathogenesis of osteoporosis. Endocrinol. Metab. Clin. North Am. (2003) 15-24
25. Lill C.A., Gerlach U.V., Eckhardt C., Goldhahn J., and Schneider E. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos. Int. 13 6 (2002) 480-486
26. Maertens C., Wei L., Tytgat J., Droogmans G., and Nilius B. Chlorotoxin does not inhibit volume-regulated, calcium-activated and cyclic AMPactivated chloride channels. Br. J. Pharmacol. 129 4 (2000) 791-801
27. Melton L. Bring back the acetyls - a novel anticancer movement. Lancet Oncol. 4 12 (2003) 710
28. Mercer B., Markland F., and Minkin C. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment. J. Bone Miner. Res. 13 3 (1998) 409-414
29. Mundy G.R. Osteoporosis into the year 2010. Br. J. Obstet. Gynaecol. 103 Suppl. 13 (1996) 32-37
30. Neuman R.E., and Logan M.A. The determination of hydroxyproline. J. Biol. Chem. 184 1 (1950) 299-306
31. Olivier B.J., Schoenmaker T., Mebius R.E., Everts V., Mulder C.J., van Nieuwkerk K.M., de Vries T.J., and van der Merwe S.W. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Hepatology 47 1 (2008) 259-267
32. Sachdeva A., Seth S., Khosla A.H., and Sachdeva S. Study of some common biochemical bone turnover markers in postmenopausal women. Indian J. Clin. Biochem. 20 1 (2005) 131-134
33. Sato M., Sardana M.K., Grasser W.A., Garsky V.M., Murray J.M., and Gould R.J. Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111 4 (1990) 1713-1723
34. Somekawa Y., and Wakabayashi A. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 79 2 (1998) 185-191
35. Stěpán J.J., Musilová J., and Pacovský V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J. Bone Miner. Res. 4 2 (1989) 193-198
36. Straub R.H., Hense H.W., Andus T., Schölmerich J., Riegger G.A., and Schunkert H. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J. Clin. Endocrinol. Metab. 85 3 (2000) 1340-1344
37. Tikader B.K., and Bastawade D.B. The fauna of India. Scorpions, scorpionida: arachnida vol. III (1983), Zoological Survey of India, Calcutta
38. Valverde P., Kawai T., and Taubman M.A. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Miner. Res. 19 1 (2004) 155-164
39. Young D.S. Effect of Disease on Clinical Lab. Tests. fourth ed. (2001), AACC